Alvotech And Dr. Reddy's Partner To Co-Develop Biosimilar To Keytruda, Targeting Global Oncology Markets

Under the terms of the agreement, the parties will be jointly responsible for developing and manufacturing the biosimilar candidate and sharing costs and responsibilities. Subject to certain exceptions, each party will have the right to commercialize the product globally.